News
Latest News
Radiant Biotherapeutics Secures $2M Grant for Next-Gen HIV Biologics
Radiant Biotherapeutics Secures $2M Grant for Next-Gen HIV Biologics Industry Partnerships & Commercialization (IP&C) at The Hospital for Sick Children (SickKids) [...]
Accelerating Innovation: IP&C’s Eighth Annual Proof of Principle Competition Awards $300,000 to Outstanding SickKids’ Projects
Accelerating Innovation: IP&C's Eighth Annual Proof of Principle Competition Awards $300,000 to Outstanding SickKids' Projects From exploring innovative approaches for epilepsy [...]
A designer peptide against the EAG2–Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma
Breaking new ground in glioblastoma research: A designer peptide against the EAG2–Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma [...]
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo Researchers at The Hospital for Sick Children [...]
Radiant Biotherapeutics Emerges from Stealth Mode with $8 Million Seed Round and Two Pharma Partnerships
Radiant Biotherapeutics Emerges from Stealth Mode with $8 Million Seed Round and Two Pharma Partnerships Radiant Biotherapeutics, a revolutionary antibody platform [...]
Novel machine-learning algorithm creates atlas of cancer with potential as universal diagnostic platform
Novel machine-learning algorithm creates atlas of cancer with potential as universal diagnostic platform In the first broad comparison of paediatric and [...]
Researchers develop novel algorithm to unlock role of cellular phenomenon in aggressive cancers
Researchers develop novel algorithm to unlock role of cellular phenomenon in aggressive cancers Scientists at The Hospital for Sick Children (SickKids) [...]
Seventh annual SickKids gap funding competition advances health-care innovations
Seventh annual SickKids gap funding competition advances health-care innovations From potential treatments for Clostridium difficile infection and medulloblastoma to a new [...]
SickKids immunotargeting technology licensed exclusively to Providence Therapeutics
SickKids immunotargeting technology licensed exclusively to Providence Therapeutics The Hospital for Sick Children (SickKids), through the SickKids Industry Partnerships & Commercialization Office, has entered [...]
Innovation Showcase returns to highlight SickKids technologies and innovators
Innovation Showcase returns to highlight SickKids technologies and innovators Summary: Annual commercialization event offers attendees access to emerging therapeutic and diagnostic [...]
